FindTrial
Sign In

Interaction of cisatracurium with nitrous oxide as quantified by closed-loop feedback control / Typpioksiduulin vaikutus sisatrakuurin annostarpeeseen käytettäessä sisatrakuurin tietokoneohjattua annostelua

Interaction of cisatracurium with nitrous oxide as quantified by closed-loop feedback control / Typpioksiduulin vaikutus sisatrakuurin annostarpeeseen käytettäessä sisatrakuurin tietokoneohjattua annostelua

Status
Active, not recruiting
Phases
Phase 1Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-006037-41-FI
Enrollment
70
Registered
2006-11-09
Start date
2006-12-21
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkimuksen kohderyhmänä ovat potilaat, joille tehdään yleisanestesiaa vaativa leikkaus, jonka kesto on vähintään 90 min. MedDRA version: 8.1 Level: PT Classification code 10002091 Term: Anaesthesia

Interventions

Trade Name: Typpioksiduuli Pharmaceutical Form: Inhalation gas INN or Proposed INN: NITROUS OXIDE CAS Number: 10024972 Trade Name: Lääketieteellinen ilma Pharmaceutical Form: Inhalation gas Other des

Sponsors

Klaus Olkkola
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026